Sage Therapeutics (SAGE)
(Delayed Data from NSDQ)
$10.99 USD
+0.52 (4.97%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $10.97 -0.02 (-0.18%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/31/2024
Time: AMC |
6/2024 | $-1.66 | 0.04% |
Earnings Summary
For their last quarter, Sage Therapeutics (SAGE) reported earnings of -$1.80 per share, missing the Zacks Consensus Estimate of -$1.63 per share. This reflects a negative earnings surprise of 10.43%. Look out for SAGE's next earnings release on July 31, 2024. For the next earning release, we expect the company to report earnings of -$1.66 per share, reflecting a year-over-year increase of 38.06%.
Earnings History
Price & Consensus
Zacks News for SAGE
Ardelyx (ARDX) Expected to Beat Earnings Estimates: Should You Buy?
SAGE: What are Zacks experts saying now?
Zacks Private Portfolio Services